Pyridine-derivatives

Poladian, Q; Sahin, O; Karakurt, T; Ilhan-Ceylan, B; Kurt, Y in [Poladian, Qumars; Ilhan-Ceylan, Berat; Kurt, Yasemin] Istanbul Univ Cerrahpasa, Engn Fac, Dept Chem, TR-34320 Istanbul, Turkey; [Sahin, Onur] Sinop Univ, Fac Hlth Sci, Dept Occupat Hlth & Safety, TR-57000 Sinop, Turkey; [Karakurt, Tuncay] Kirsehir Ahi Evran Univ, Fac Engn Architecture, Dept Chem & Proc Engn, TR-40100 Kirsehir, Turkey published A new zinc(II) complex with N2O2-tetradentate schiff-base derived from pyridoxal-S-methylthiosemicarbazone: Synthesis, characterization, crystal structure, DFT, molecular docking and antioxidant activity studies in 2021.0, Cited 69.0. COA of Formula: C8H10ClNO3. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5.

A new unsymmetrical N2O2-tetradentate Schiff-base complex of zinc(II) was synthesized by the template reaction of pyridoxal-S-methylthiosemicarbazone and 2-hydroxy-4-methoxy-benzaldehyde as starting compounds. S-methylthiosemicarbazone (1) and zinc(II) complex [Zn(L)CH3OH] ( 2) were characterized by elemental analysis, FT-IR, UV-visible, H-1, and C-13 NMR spectra. The molecular structure of the complex (2) was determined by single crystal X-ray diffraction technique. The structure consists of a distorted square-pyramidal geometry around the central metal, Zn(II). Quantum chemical calculations were carried out using density functional theory DFT/B3LYP, 6-31G (d), and LanL2DZ basis sets for theoretical characterization of the compounds. The experimental and theoretical data were compared comprehensively. The potential energy distribution (PED) analysis was performed for the assignment of vibration frequencies. In order to support in vitro studies, molecular docking studies have been carried out so that the title compound can be an inhibitor of Epidermal Growth Factor Receptor (1 m17), and the relationship between calculated HOMO energies and docking studies has been examined. In addition, the total antioxidant capacity (as TEAC value) and free radical scavenging activity of the compounds were determined by Cupric Reducing Antioxidant Capacity (CUPRAC) and 1,1-diphenyl-2-picryl hydrazyl (DPPH) methods, respectively. (C) 2021 Elsevier Ltd. All rights reserved.

About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Poladian, Q; Sahin, O; Karakurt, T; Ilhan-Ceylan, B; Kurt, Y or concate me.. COA of Formula: C8H10ClNO3

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

HPLC of Formula: C6H5NO. Ben Gaied, L; Fincias, N; Garrec, J; El Kaim, L in [Ben Gaied, Lilia] Inst Preparatoire Etud Sci & Tech, Lab Physicochim Microstruct & Microsyst, BP 51, Tunis 2070, Tunisia; [Fincias, Nicolas; Garrec, Julian; El Kaim, Laurent] Inst Polytech Paris, LSO, Ecole Polytech, CNRS,ENSTA Paris UMR 7652, 828 Bd Marechaux, F-91128 Palaiseau, France published 5-endo-dig Cyclization of O-Propargyl Mandelic Acid Amides towards 2,5-Dihydrofurans in 2019.0, Cited 71.0. The Name is 3-Pyridinecarboxaldehyde. Through research, I have a further understanding and discovery of 500-22-1.

5-endo-dig cyclization of O-propargyloxyamides, obtained through a Passerini reaction mediated by boric acid and subsequent propargylation, affords 2,5-dihydrofurans in the presence of tert-butylate. The mechanism of the reaction was studied by using DFT calculations and the results were compared with the behavior of analogous N-propargylamide derivatives.

HPLC of Formula: C6H5NO. About 3-Pyridinecarboxaldehyde, If you have any questions, you can contact Ben Gaied, L; Fincias, N; Garrec, J; El Kaim, L or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

In 2020.0 ORG LETT published article about MANNICH-TYPE REACTIONS; BOND FORMATION; ARYL HALIDES; ALPHA-AMINO; ASYMMETRIC HYDROGENATION; BENZOPHENONE IMINE; DIRECT ACCESS; SCHIFF-BASES; DERIVATIVES; ACTIVATION in [Kondo, Yuta; Kadota, Tetsuya; Hirazawa, Yoshinobu; Morisaki, Kazuhiro; Morimoto, Hiroyuki; Ohshima, Takashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan; [Morisaki, Kazuhiro] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan in 2020.0, Cited 67.0. The Name is Phenyl(pyridin-2-yl)methanone. Through research, I have a further understanding and discovery of 91-02-1. COA of Formula: C12H9NO

N-Unprotected ketimines are useful substrates and intermediates for synthesizing valuable nitrogen-containing compounds, but their potential applicability is limited by the available synthetic methods. To address this issue, we report a scandium(III) triflate catalyzed direct synthesis of N-unprotected ketimines. Using commercially available reagents and Lewis acid catalysts, ketones were directly transformed into the corresponding N-unprotected ketimines in high yields with broad functional group tolerance, even in multigram scales. The reactions were readily applicable for one-pot synthesis of important compounds such as a glycine Schiff base without isolation of N-unprotected ketimine intermediates. Preliminary mechanistic studies to clarify the reaction mechanism are also described.

COA of Formula: C12H9NO. About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Kondo, Y; Kadota, T; Hirazawa, Y; Morisaki, K; Morimoto, H; Ohshima, T or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

An article Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: A pooled analysis of prospective cohort studies WOS:000559724500001 published article about CORONARY-HEART-DISEASE; BETA-CELL TURNOVER; ADIPOSE-TISSUE; COFFEE CONSUMPTION; PLASMA; RISK; ASSOCIATION; BIOMARKERS; CANCER; PHOSPHOLIPIDS in [Imamura, Fumiaki; Koulman, Albert; Wareham, Nick J.; Forouhi, Nita G.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Fretts, Amanda M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Marklund, Matti; Riserus, Ulf] Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Nutr & Metab, Uppsala, Sweden; [Marklund, Matti; Wu, Jason H. Y.] Univ New South Wales, George Inst Global Hlth, Fac Med, Sydney, NSW, Australia; [Marklund, Matti; Micha, Renata; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Ardisson Korat, Andres V.; Hu, Frank] Harvard TH Chan Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA USA; [Ardisson Korat, Andres V.; Hu, Frank; Sun, Qi] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Ardisson Korat, Andres V.; Djousse, Luc; Hu, Frank; Sun, Qi] Harvard Med Sch, Boston, MA 02115 USA; [Yang, Wei-Sin; Chien, Kuo-Liong; Chen, Yun-yu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei, Taiwan; [Lankinen, Maria; Virtanen, Jyrki K.; Tuomainen, Tomi-Pekka; Uusitupa, Matti] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Qureshi, Waqas] Wake Forest Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, Winston Salem, NC 27101 USA; [Helmer, Catherine; Rajaobelina, Kalina; Samieri, Cecilia] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, UMR 1219, Bordeaux, France; [Chen, Tzu-An; Wood, Alexis C.; Senn, Mackenzie] USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Baylor Coll Med, Houston, TX USA; [Wong, Kerry; Bassett, Julie K.; Giles, Graham G.; Hodge, Allison] Canc Council Victoria, Canc Epidemiol Div, Melbourne, Vic, Australia; [Murphy, Rachel] Univ British Columbia, Sch Populat Publ & Hlth, Ctr Excellence Canc Prevent, Fac Med, Vancouver, BC, Canada; [Tintle, Nathan] Dordt Univ, Dept Math & Stat, Sioux Ctr, IA USA; [Yu, Chaoyu Ian; McKnight, Barbara] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Brouwer, Ingeborg A.] Vrije Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Dept Hlth Sci, Fac Sci, Amsterdam, Netherlands; [Chien, Kuo-Liong; Chen, Yun-yu] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [del Gobbo, Liana C.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Djousse, Luc] Brigham & Womens Hosp, Dept Med, Div Aging, 75 Francis St, Boston, MA 02115 USA; [Geleijnse, Johanna M.; de Goede, Janette; Soedamah-Muthu, Sabita S.] Wageningen Univ, Div Human Nutr & Hlth, Wageningen, Netherlands; [Giles, Graham G.; Hodge, Allison] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Giles, Graham G.] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic, Australia; [Gudnason, Vilmundur] Iceland Heart Assoc Res Inst, Kopavogur, Iceland; [Harris, William S.] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Sioux Falls, SD USA; [Harris, William S.] OmegaQuant Analyt, Sioux Falls, SD USA; [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Nutr Biomarker Lab, Cambridge, England; [Koulman, Albert] Univ Cambridge, Natl Inst Hlth Res, Addenbrookes Hosp, Biomed Res Ctr,Core Metabol & Lipid Lab, Cambridge, England; [Koulman, Albert] MRC, Elsie Widdowson Lab, Cambridge, England; [Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Dept Med, Kuopio, Finland; [Lind, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lin, Hung-Ju] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Robinson, Jennifer G.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Prevent Intervent Ctr, Iowa City, IA USA; [Siscovick, David S.] New York Acad Med, New York, NY USA; [Soedamah-Muthu, Sabita S.] Tilburg Univ, Dept Med & Clin Psychol, Ctr Res Psychol & Somat Disorders, Tilburg, Netherlands; [Soedamah-Muthu, Sabita S.] Univ Reading, Inst Food Nutr & Hlth, Reading, Berks, England; [Sotoodehnia, Nona; Lemaitre, Rozenn N.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Tsai, Michael Y.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Wagenknecht, Lynne E.] Wake Forest Sch Med, Publ Hlth Sci, Winston Salem, NC 27101 USA in 2020.0, Cited 47.0. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5. Formula: C8H10ClNO3

Background De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). Methods and findings Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970-1973 to 2006-2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3-75.5 years; % women = 20.4%62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-varianceweighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41-1.66; p< 0.001) for 16:0, 1.40 (1.33-1.48; p< 0.001) for 16:1n-7, 1.14 (1.05-1.22; p = 0.001) for 18:0, and 1.16 (1.07-1.25; p< 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I-2 = 51.1%-73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94-1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors. Conclusions Concentrations of fatty acids in the DNL were positively associated with T2D incidence. Our findings support further work to investigate a possible role of DNL and individual fatty acids in the development of T2D. Formula: C8H10ClNO3. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Imamura, F; Fretts, AM; Marklund, M; Ardisson Korat, AV; Yang, WS; Lankinen, M; Qureshi, W; Helmer, C; Chen, TA; Virtanen, JK; Wong, K; Bassett, JK; Murphy, R; Tintle, N; Yu, CI; Brouwer, IA; Chien, KL; Chen, Yy; Wood, AC; del Gobbo, LC; Djousse, L; Geleijnse, JM; Giles, GG; de Goede, J; Gudnason, V; Harris, WS; Hodge, A; Hu, F; Koulman, A; Laakso, M; Lind, L; Lin, HJ; McKnight, B; Rajaobelina, K; Riserus, U; Robinson, JG; Samieri, C; Senn, M; Siscovick, DS; Soedamah-Muthu, SS; Sotoodehnia, N; Sun, Q; Tsai, MY; Tuomainen, TP; Uusitupa, M; Wagenknecht, LE; Wareham, NJ; Wu, JHY; Micha, R; Lemaitre, RN; Mozaffarian, D; Forouhi, NG or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Application In Synthesis of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. In 2021.0 POLYHEDRON published article about TRANSITION-METAL-COMPLEXES; EFFECTIVE CORE POTENTIALS; GROWTH-FACTOR RECEPTOR; THIOSEMICARBAZONE DERIVATIVES; BIOLOGICAL-ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; COPPER(II) COMPLEXES; LIGANDS; NICKEL(II); ANTITUMOR in [Poladian, Qumars; Ilhan-Ceylan, Berat; Kurt, Yasemin] Istanbul Univ Cerrahpasa, Engn Fac, Dept Chem, TR-34320 Istanbul, Turkey; [Sahin, Onur] Sinop Univ, Fac Hlth Sci, Dept Occupat Hlth & Safety, TR-57000 Sinop, Turkey; [Karakurt, Tuncay] Kirsehir Ahi Evran Univ, Fac Engn Architecture, Dept Chem & Proc Engn, TR-40100 Kirsehir, Turkey in 2021.0, Cited 69.0. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5.

A new unsymmetrical N2O2-tetradentate Schiff-base complex of zinc(II) was synthesized by the template reaction of pyridoxal-S-methylthiosemicarbazone and 2-hydroxy-4-methoxy-benzaldehyde as starting compounds. S-methylthiosemicarbazone (1) and zinc(II) complex [Zn(L)CH3OH] ( 2) were characterized by elemental analysis, FT-IR, UV-visible, H-1, and C-13 NMR spectra. The molecular structure of the complex (2) was determined by single crystal X-ray diffraction technique. The structure consists of a distorted square-pyramidal geometry around the central metal, Zn(II). Quantum chemical calculations were carried out using density functional theory DFT/B3LYP, 6-31G (d), and LanL2DZ basis sets for theoretical characterization of the compounds. The experimental and theoretical data were compared comprehensively. The potential energy distribution (PED) analysis was performed for the assignment of vibration frequencies. In order to support in vitro studies, molecular docking studies have been carried out so that the title compound can be an inhibitor of Epidermal Growth Factor Receptor (1 m17), and the relationship between calculated HOMO energies and docking studies has been examined. In addition, the total antioxidant capacity (as TEAC value) and free radical scavenging activity of the compounds were determined by Cupric Reducing Antioxidant Capacity (CUPRAC) and 1,1-diphenyl-2-picryl hydrazyl (DPPH) methods, respectively. (C) 2021 Elsevier Ltd. All rights reserved.

Application In Synthesis of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Poladian, Q; Sahin, O; Karakurt, T; Ilhan-Ceylan, B; Kurt, Y or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

HPLC of Formula: C8H10ClNO3. Mondal, S; Chakraborty, M; Mondal, A; Pakhira, B; Mukhopadhyay, SK; Banik, A; Sengupta, S; Chattopadhyay, SK in [Mondal, Satyajit; Chakraborty, Moumita; Mondal, Antu; Pakhira, Bholanath; Chattopadhyay, Shyamal Kumar] Indian Inst Engn Sci & Technol, Dept Chem, Sibpur 711103, Howrah, India; [Mukhopadhyay, Subhra Kanti; Banik, Avishek] Univ Burdwan, Dept Microbiol, Burdwan 713104, W Bengal, India; [Sengupta, Swaraj] Birla Inst Technol, Dept Chem, Ranchi 835215, Jharkhand, India published Crystal structure, spectroscopic, DNA binding studies and DFT calculations of a Zn(II) complex in 2019.0, Cited 67.0. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5.

Herein we report, a mononuclear, highly fluorescent zinc(ii) complex Zn(L)(N-3)(H2O) (1) that was prepared by an easy one pot method, in which the tridentate Schiff base ligand (E)-4-((2-(dimethylamino)ethylimino)methyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol (HL) was generated in situ. The compound is characterized by various spectroscopic techniques, and its structure was determined by single crystal X-ray diffraction studies. DFT calculations were used to understand the electronic structures of the ligand and the complex, and TD-DFT calculations were performed to interpret the nature of the electronic transitions observed in their UV-vis spectra. In the complex, Zn(II) is found to be penta-coordinated with one azide ligand, an aqua ligand and a monoanionic tridentate N,N,O-donor ligand. In an aqueous methanol (1:9 by volume) solution, at the physiological pH (0.01 M Tris-HCl buffer, pH 7.4), compound 1 exhibits an intense greenish blue fluorescence (lambda(ex) 390 nm, lambda(em) 462 nm), whose intensity is about 17-fold stronger than that of the free ligand. Compound 1 is found to show significant DNA binding activity. The pyridoxal appended tridentate ligand can be used for the bio-imaging of Zn(II).

HPLC of Formula: C8H10ClNO3. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Mondal, S; Chakraborty, M; Mondal, A; Pakhira, B; Mukhopadhyay, SK; Banik, A; Sengupta, S; Chattopadhyay, SK or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

I found the field of Chemistry; Crystallography very interesting. Saw the article Cobalt complexes containing salen-type pyridoxal ligand and DMSO for cycloaddition of carbon dioxide to propylene oxide published in 2020.0. Computed Properties of C8H10ClNO3, Reprint Addresses Park, HR; Lee, J (corresponding author), Chonnam Natl Univ, Dept Chem, 300 Yongbong Dong, Gwangju 500757, South Korea.. The CAS is 65-22-5. Through research, I have a further understanding and discovery of 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride

Cobalt complexes containing a salen-type pyridoxal ligand with pyridine were synthesized as a new Co (III) catalytic system for the cycloaddition of carbon dioxide. Two cobalt(III) complexes possessing a salen-type pyridoxyl ligand were synthesized by the reaction of pyridoxal ligands (pyr(2)en = (N,N’-bis (pyridoxylideneiminato)ethylene) and pyr(2)cy = (N,N’-bis(pyridoxylideneiminato)cyclohexane)) and Co (OAc)(2) and characterized by various analytical methods, including infrared spectroscopy and high-resolution mass analysis. Single-crystal X-ray crystallography analysis confirmed that the cobalt pyr(2)en complex had a distorted octahedral structure: the tetradentate Schiff base ligand binds the cobalt metal in one plane, and the metal center adopts an octahedral geometry by the additional coordination of acetate and dimethyl sulfoxide. The synthesized complexes were used as catalysts in the cycloaddition of carbon dioxide (CO2) to propylene oxide. The catalysts showed high activity for cycloaddition between CO2 and epoxides, even at a low loading (0.5 mol%), in the presence of various cocatalysts. (C) 2020 Elsevier Ltd. All rights reserved.

About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Hwang, S; Ryu, JY; Jung, SH; Park, HR; Lee, J or concate me.. Computed Properties of C8H10ClNO3

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

An article Structural divergence in binuclear Cu(ii) pyridoxal Schiff base complexes probed by co-ligands: catecholase mimetic activity and sulphide ion sensing WOS:000554833200003 published article about 2,6-DIACETYLPYRIDINE DAP HYDRAZONES; CRYSTAL-STRUCTURES; SPECTROSCOPIC PROPERTIES; MAGNETIC-PROPERTIES; AROYL HYDRAZONES; II COMPLEXES; COPPER(II); OXIDASE; COORDINATION; MN(II) in [Chakraborty, Moumita; Mondal, Antu; Chattopadhyay, Shyamal Kumar] Indian Inst Engn Sci & Technol, Dept Chem, Sibpur 711103, Howrah, India in 2020.0, Cited 74.0. Computed Properties of C8H10ClNO3. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5

Three hydroxymethyl bridged Cu(ii) complexes of a pyridoxal Schiff base ligand 4-((E)-(2-(pyridin-2-yl)ethylimino)methyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol (LH) have been synthesized and characterized on the basis of spectroscopic, elctrochemical and structural properties. The X-ray crystal structures of the complexes reveal dual denticity of the ligand, bidenticity in the absence of a co-ligand as in complex1, and tridenticity in the presence of a co-ligand such as SCN-/N(CN)(2)(-)as in complexes2and3. The complexes, though binuclear in the solid state, exist as a monomeric unit in solution due to the exceptionally long axial Cu-O-hydroxymethyl(2.4-2.5 angstrom) bond. All three complexes show efficient catalytic activities towards the aerial oxidation of 3,5-ditertiarybutylcatechol (DTBCH2) withk(cat)values of 5.38 x 10(4)h(-1), 1.18 x 10(5)h(-1)and 1.06 x 10(5)h(-1)in methanol. Complexes1and2also act as a selective sulphide ion sensor withK(b)values of 6.6 x 10(3)M(-1)and 8.1 x 10(3)M(-1), respectively, while their respective L.O.D. values are 3.4 mu M and 3.2 mu M.

About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Chakraborty, M; Mondal, A; Chattopadhyay, SK or concate me.. Computed Properties of C8H10ClNO3

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Mohan, S; Patel, S; Barlow, D; Rojas, AC in [Mohan, Srinidi; Patel, Seema; Barlow, David; Rojas, Augusto Cardenas] Univ New England, Coll Pharm, Dept Pharmaceut Sci, Portland, ME USA published Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors in 2020.0, Cited 28.0. Product Details of 65-22-5. The Name is 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride. Through research, I have a further understanding and discovery of 65-22-5.

Purpose: We investigated Nw-hydroxy L-Arginine (NOHA) predictive response in serous ovarian carcinoma based on estrogen-hormone receptor expression status; and assessed the distinctive NOHA response between estrogen-receptor-negative (ER-) tumor subtypes of ovarian and breast cancer. Materials/methods: Three-dimensional (3D) spheroids models of ER- and estrogen-receptor-positive (ER+) from breast and ovarian tumor, cultured for 9 weeks, were assayed for cellular levels of inducible nitric oxide synthase (NOS2), nitric oxide (as total nitrite) and L-Arginine, and compared to NOHA in culture medium. Statistical difference was set at p < 0.01. Results: Nine-week in vitro studies showed a progressive NOHA reduction in culture medium by at least 0.4-0.8 fold, and 0.65-0.92 fold only in the ER-breast tumor and ER-ovarian tumor 3D spheroids, respectively; with increases in cellular NOS2 and nitric-oxide levels, by at least 1.0-2.45 fold in both ER-tumor subtype 3D spheroids (p < 0.01; n = 6). Within ER-subtypes, medium NOHA decreased by >= 38.9% in ovarian cancer over breast cancer 3D-spheroids, with cellular increases in NOS2 (by >= 17.4%), and nitric oxide (by >= 18.8%). Cellular L-Arginine to medium NOHA ratio was higher, and by at least 6.5-22.5 fold in ER-breast tumor 3D-spheroids, and at least 10-70 fold in ER-ovarian tumor 3D spheroids, than in ER+ and control conditions; and was >= 48% higher in ER-ovarian cancer than in ER-breast cancer 3D-spheroids. Conclusions: The present study shows NOHA as a sensitive and selective indicator differentiating and distinguishing ER-subtypes based on the tumor grade.

Product Details of 65-22-5. About 3-Hydroxy-5-(hydroxymethyl)-2-methylisonicotinaldehyde hydrochloride, If you have any questions, you can contact Mohan, S; Patel, S; Barlow, D; Rojas, AC or concate me.

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem

Patil, SG; Jadhav, JS; Sankpal, ST in [Patil, Suhas G.] St Rawool Maharaj Mahavidyalaya, Kudal 416520, MS, India; [Jadhav, Jagannath S.] Shivaji Univ, Dept Chem, Kolhapur 416004, MS, India; [Patil, Suhas G.; Sankpal, Sagar T.] ASP Coll, Dept Chem, Ratnagiri 415804, MS, India published Mg3N2-assisted one-pot synthesis of 1,3-disubstituted imidazo[1,5-a]pyridine in 2020.0, Cited 58.0. Safety of Phenyl(pyridin-2-yl)methanone. The Name is Phenyl(pyridin-2-yl)methanone. Through research, I have a further understanding and discovery of 91-02-1.

A novel Mg3N2-assisted one-pot annulation strategy has been developed via cyclo-condensation reaction of 2-pyridyl ketones with alkyl glyoxylates or aldehydes, allowing the formation of imidazo[1,5-a]pyridines exclusively with an exellent yield.

About Phenyl(pyridin-2-yl)methanone, If you have any questions, you can contact Patil, SG; Jadhav, JS; Sankpal, ST or concate me.. Safety of Phenyl(pyridin-2-yl)methanone

Reference:
Pyridine – Wikipedia,
,Pyridine | C5H5N – PubChem